Related Experiment Video

Updated: Jun 11, 2026

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
05:58

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format

Published on: August 20, 2018

A study of three polymorphic sites of ADA gene in colon cancer

C Spina1, P Saccucci, E Cozzoli

  • 1Department of Surgery, University of Rome Tor Vergata, Rome, Italy.

Cancer Investigation
|July 2, 2010
PubMed

Insights

Genetic variations in adenosine deaminase (ADA) influence colon cancer immunity. Specific ADA gene polymorphisms are linked to altered immune responses in patients, suggesting a role in anti-tumor immunity.

Area of Science:

  • Immunology
  • Genetics
  • Oncology

Background:

  • Adenosine suppresses anti-tumor immune responses within the tumor microenvironment.
  • Adenosine deaminase (ADA) regulates adenosine levels and possesses extraenzymatic functions, impacting immune cell signaling.
  • ADA acts as a costimulatory molecule for adenosine receptors and/or CD26.

Purpose of the Study:

  • To investigate the association between specific polymorphic sites of the ADA gene and colon cancer.
  • To determine if ADA gene variations influence cell-mediated anti-tumor immune responses in colon cancer patients.

Main Methods:

  • Genotyping of ADA₁, ADA₂, and ADA₆ polymorphic sites in 109 colon cancer patients and 246 healthy controls from Rome.
  • Haplotype analysis was performed to assess the frequency of specific ADA gene variants.

Main Results:

  • The ADA₁*2/ADA₂*1 haplotype was more prevalent in colon cancer patients compared to controls.
  • The ADA₁*2/ADA₂*2 haplotype showed reduced representation in colon cancer patients.
  • The ADA₂*2/ADA₆*2 haplotype was less frequent in patients than in controls.

Conclusions:

  • Polymorphisms in the ADA gene may affect cell-mediated anti-tumor immunity in colon cancer.
  • ADA gene variations could influence immune responses by modulating adenosine levels and/or extraenzymatic functions.
  • These findings highlight the potential role of ADA genetics in colon cancer immunobiology.

More Related Videos

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform06:21

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Published on: May 10, 2024

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...